|
1
|
Trojnarska O, Grajek S, Katarzyński S and
Kramer L: Predictors of mortality in adult patients with congenital
heart disease. Cardiol J. 16:341–347. 2009.PubMed/NCBI
|
|
2
|
Rosamond W, Flegal K, Furie K, Go A,
Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et
al: American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics - 2008
update: A report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
117:e25–e146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khairy P, Ionescu-Ittu R, Mackie AS,
Abrahamowicz M, Pilote L and Marelli AJ: Changing mortality in
congenital heart disease. J Am Coll Cardiol. 56:1149–1157. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruneau BG: The developmental genetics of
congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olson EN: Gene regulatory networks in the
evolution and development of the heart. Science. 313:1922–1927.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Olson EN: A decade of discoveries in
cardiac biology. Nat Med. 10:467–474. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang DZ: MicroRNAs in cardiac development
and remodeling. Pediatr Cardiol. 31:357–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kiriakidou M, Tan GS, Lamprinaki S, De
Planell-Saguer M, Nelson PT and Mourelatos Z: An mRNA m7G cap
binding-like motif within human Ago2 represses translation. Cell.
129:1141–1151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Humphreys DT, Westman BJ, Martin DI and
Preiss T: MicroRNAs control translation initiation by inhibiting
eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc
Natl Acad Sci USA. 102:16961–16966. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu N and Olson EN: MicroRNA regulatory
networks in cardiovascular development. Dev Cell. 18:510–525. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai B, Pan Z and Lu Y: The roles of
microRNAs in heart diseases: A novel important regulator. Curr Med
Chem. 17:407–411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rota R, Ciarapica R, Giordano A, Miele L
and Locatelli F: MicroRNAs in rhabdomyosarcoma: Pathogenetic
implications and translational potentiality. Mol Cancer.
10:1202011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thum T, Galuppo P, Wolf C, Fiedler J,
Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J,
Haverich A, et al: MicroRNAs in the human heart: A clue to fetal
gene reprogramming in heart failure. Circulation. 116:258–267.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Ransom JF, Li A, Vedantham V, von
Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ and
Srivastava D: Dysregulation of cardiogenesis, cardiac conduction,
and cell cycle in mice lacking miRNA-1-2. Cell. 129:303–317. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Rooij E, Sutherland LB, Qi X,
Richardson JA, Hill J and Olson EN: Control of stress-dependent
cardiac growth and gene expression by a microRNA. Science.
316:575–579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carè A, Catalucci D, Felicetti F, Bonci D,
Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, et al:
MicroRNA-133 controls cardiac hypertrophy. Nat Med. 13:613–618.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi R, Qin Y, Macara IG and Cullen BR:
Exportin-5 mediates the nuclear export of pre-microRNAs and short
hairpin RNAs. Genes Dev. 17:3011–3016. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bernstein E, Kim SY, Carmell MA, Murchison
EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV and Hannon
GJ: Dicer is essential for mouse development. Nat Genet.
35:215–217. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wienholds E, Koudijs MJ, van Eeden FJ,
Cuppen E and Plasterk RH: The microRNA-producing enzyme Dicer1 is
essential for zebrafish development. Nat Genet. 35:217–218. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JF, Murchison EP, Tang R, Callis TE,
Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman
CH, et al: Targeted deletion of Dicer in the heart leads to dilated
cardiomyopathy and heart failure. Proc Natl Acad Sci USA.
105:2111–2116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen JF, Mandel EM, Thomson JM, Wu Q,
Callis TE, Hammond SM, Conlon FL and Wang DZ: The role of
microRNA-1 and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Srivastava D, Thomas T, Lin Q, Kirby ML,
Brown D and Olson EN: Regulation of cardiac mesodermal and neural
crest development by the bHLH transcription factor, dHAND. Nat
Genet. 16:154–160. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu N, Williams AH, Kim Y, McAnally J,
Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R and
Olson EN: An intragenic MEF2-dependent enhancer directs
muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad
Sci USA. 104:20844–20849. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu N, Bezprozvannaya S, Williams AH, Qi
X, Richardson JA, Bassel-Duby R and Olson EN: microRNA-133a
regulates cardiomyocyte proliferation and suppresses smooth muscle
gene expression in the heart. Genes Dev. 22:3242–3254. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goddeeris MM, Rho S, Petiet A, Davenport
CL, Johnson GA, Meyers EN and Klingensmith J: Intracardiac
septation requires hedgehog-dependent cellular contributions from
outside the heart. Development. 135:1887–1895. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Latronico MV, Catalucci D and Condorelli
G: MicroRNA and cardiac pathologies. Physiol Genomics. 34:239–242.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
O'Brien JE Jr, Kibiryeva N, Zhou XG,
Marshall JA, Lofland GK, Artman M, Chen J and Bittel DC: Noncoding
RNA expression in myocardium from infants with tetralogy of Fallot.
Circ Cardiovasc Genet. 5:279–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu ZB, Han SP, Bai YF, Zhu C, Pan Y and
Guo XR: microRNA expression profiling in fetal single ventricle
malformation identified by deep sequencing. Int J Mol Med.
29:53–60. 2012.PubMed/NCBI
|
|
33
|
Omran A, Elimam D, Webster KA, Shehadeh LA
and Yin F: MicroRNAs: A new piece in the paediatric cardiovascular
disease puzzle. Cardiol Young. 23:642–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ikeda S, Kong SW, Lu J, Bisping E, Zhang
H, Allen PD, Golub TR, Pieske B and Pu WT: Altered microRNA
expression in human heart disease. Physiol Genomics. 31:367–373.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tatsuguchi M, Seok HY, Callis TE, Thomson
JM, Chen JF, Newman M, Rojas M, Hammond SM and Wang DZ: Expression
of microRNAs is dynamically regulated during cardiomyocyte
hypertrophy. J Mol Cell Cardiol. 42:1137–1141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
van Rooij E, Sutherland LB, Thatcher JE,
DiMaio JM, Naseem RH, Marshall WS, Hill JA and Olson EN:
Dysregulation of microRNAs after myocardial infarction reveals a
role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA.
105:13027–13032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fichtlscherer S, Zeiher AM, Dimmeler S and
Sessa WC: Circulating microRNAs: Biomarkers or mediators of
cardiovascular diseases? Arterioscler Thromb Vasc Biol.
31:2383–2390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tijsen AJ, Pinto YM and Creemers EE:
Circulating microRNAs as diagnostic biomarkers for cardiovascular
diseases. Am J Physiol Heart Circ Physiol. 303:H1085–H1095. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hunter JJ and Chien KR: Signaling pathways
for cardiac hypertrophy and failure. N Engl J Med. 341:1276–1283.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Callis TE, Pandya K, Seok HY, Tang RH,
Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, et al:
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction
in mice. J Clin Invest. 119:2772–2786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matkovich SJ, Hu Y, Eschenbacher WH, Dorn
LE and Dorn GW II: Direct and indirect involvement of microRNA-499
in clinical and experimental cardiomyopathy. Circ Res. 111:521–531.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li C, Fang Z, Jiang T, Zhang Q, Liu C,
Zhang C and Xiang Y: Serum microRNAs profile from genome-wide
serves as a fingerprint for diagnosis of acute myocardial
infarction and angina pectoris. BMC Med Genomics. 6:162013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kuwabara Y, Ono K, Horie T, Nishi H, Nagao
K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, et al:
Increased microRNA-1 and microRNA-133a levels in serum of patients
with cardiovascular disease indicate myocardial damage. Circ
Cardiovasc Genet. 4:446–454. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ai X, Curran JW, Shannon TR, Bers DM and
Pogwizd SM: Ca2+/calmodulin-dependent protein kinase
modulates cardiac ryanodine receptor phosphorylation and
sarcoplasmic reticulum Ca2+ leak in heart failure. Circ
Res. 97:1314–1322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He
J, Qin YW and Jing Q: Circulating microRNA: A novel potential
biomarker for early diagnosis of acute myocardial infarction in
humans. Eur Heart J. 31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang L, Chen X, Su T, Li H, Huang Q, Wu
D, Yang C and Han Z: Circulating miR-499 are novel and sensitive
biomarker of acute myocardial infarction. J Thorac Dis. 7:303–308.
2015.PubMed/NCBI
|
|
49
|
Hosoda T, Zheng H, Cabral-da-Silva M,
Sanada F, Ide-Iwata N, Ogórek B, Ferreira-Martins J, Arranto C,
D'Amario D, del Monte F, et al: Human cardiac stem cell
differentiation is regulated by a mircrine mechanism. Circulation.
123:1287–1296. 2011. View Article : Google Scholar : PubMed/NCBI
|
